ArticleMedicine2025
Integrated network pharmacology and molecular docking reveal multi-target hepatotoxic mechanisms of Xanthii fructus.
Article in Medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Xanthii fructus (XF), a traditional Chinese medicine, is commonly used for anti-inflammatory and analgesic purposes; however, its hepatotoxicity limits its use to some extent and the underlying mechanisms remain unclear. The present study aimed to explore the key targets and molecular pathways of XF-induced liver injury through an integrated network toxicology and molecular docking approach. Potential hepatotoxic components of XF were screened using the TCMSP and comparative toxicogenomics database databases. Targets associated with these components and liver injury were identified via SwissTargetPrediction, GeneCards, and online Mendelian inheritance in man. Protein-protein interaction networks were constructed using STRING and analyzed with Cytoscape. The Metascape platform was used for gene ontology/Kyoto encyclopedia of genes and genomes enrichment analysis, and molecular docking was performed to validate the interactions between the key components and targets. Five hepatotoxic active ingredients were finally screened, involving 74 hepatotoxic targets, and significantly enriched pathways were uncovered through rigorous Kyoto encyclopedia of genes and genomes analysis. The most prominent was pathways in cancer [P <.001; false discovery rate (q-value) <0.001], followed by Hepatitis B [P <.001; false discovery rate (q-value) <0.001]. Among them, TP53, HSP90AA1, JUN, and EP300 served as core targets. Molecular docking confirmed the strong binding affinity between the key targets and hepatotoxic components (binding energy: -6.83 to -9.28 kcal/mol). This study provides a preliminary framework for XF-induced hepatotoxicity, highlighting multi-component, multi-target interactions. Mechanistic predictions require preclinical validation. Future work should validate these findings experimentally and explore detoxification strategies to enable safer clinical use of XF.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.